The University of Leicester’s Diabetes Centre are working with a medical device company who have provided funding for an investigator initiated study using a CE marked device in a new patient population.
Hybrid systems have been CE marked for use in type one diabetes, but we now want to test the efficacy and safety in type two diabetes. As this may open up a new indication, we suspect this study will require MHRA approval and an MHRA compatible database to store the study data.
We would love to hear from any companies who may be able to provide a suitable database for the study. In the first instance, please email iph@le.ac.uk so that we can arrange further conversations with the study team.
Opportunity provided by the University of Leicester.